Glucose 5% w/v Solution for Infusion Ирландия - английский - HPRA (Health Products Regulatory Authority)

glucose 5% w/v solution for infusion

fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 5 percent weight/volume - solutions for parenteral nutrition; carbohydrates

Glucose 5% w/v, Solution for Infusion Ирландия - английский - HPRA (Health Products Regulatory Authority)

glucose 5% w/v, solution for infusion

fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 5 percent weight/volume - solutions for parenteral nutrition; carbohydrates

DIANEAL 1mmol Calcium in 4.25% Glucose Peritoneal dialysis solution Австралия - английский - Department of Health (Therapeutic Goods Administration)

dianeal 1mmol calcium in 4.25% glucose peritoneal dialysis solution

vantive pty ltd - glucose, quantity: 42.5 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; magnesium chloride hexahydrate, quantity: 0.0508 g/l; calcium chloride dihydrate, quantity: 0.147 g/l - solution, dialysis - excipient ingredients: water for injections - dianeal pd-2, pd-4 and 1mmol calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis.

STAY SAFE BALANCE 4.25% glucose 1.75 mmolL calcium peritoneal dialysis solution bag Малайзия - английский - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

stay safe balance 4.25% glucose 1.75 mmoll calcium peritoneal dialysis solution bag

fresenius medical care malaysia sdn bhd - sodium chloride (nacl); calcium chloride dihydrate ph. eur.; magnesium chloride hexahydrate pheur; glucose monohydrate, ph eur; sodium lactate solution (50%) -

STAY SAFE BALANCE 4.25% glucose 1.25 mmolL calcium peritoneal dialysis solution bag Малайзия - английский - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

stay safe balance 4.25% glucose 1.25 mmoll calcium peritoneal dialysis solution bag

fresenius medical care malaysia sdn bhd - sodium chloride ph eur; calcium chloride dihydrate ph. eur.; magnesium chloride hexahydrate pheur; glucose monohydrate, ph eur; sodium lactate solution (50%) -

BICA VERA  1.5 % GLUCOSE 1.75 MMOLL CALCIUM Израиль - английский - Ministry of Health

bica vera 1.5 % glucose 1.75 mmoll calcium

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; calcium chloride dihydrate; glucose monohydrate; glucose monohydrate; magnesium chloride hexahydrate; magnesium chloride hexahydrate; sodium chloride; sodium chloride; sodium hydrogen carbonate; sodium hydrogen carbonate - solution for peritoneal dialysis - sodium chloride 11.57 g/l; calcium chloride dihydrate 0.5145 g/l; magnesium chloride hexahydrate 0.2033 g/l; sodium chloride 5.786 g/l; glucose monohydrate 33.0 g/l; glucose monohydrate 16.5 g/l; magnesium chloride hexahydrate 0.1017 g/l; calcium chloride dihydrate 0.2573 g/l; sodium hydrogen carbonate 2.940 g/l; sodium hydrogen carbonate 5.880 g/l - combinations of electrolytes - end-stage (decompensated ) chronic renal failure of any origin treated with peritoneal dialysis.17/10/2017 בקשה לשינוי משטר מינון שינוי משטר מינון בהתאם למאושר באירופה

OLANZAPINE tablet Соединенные Штаты - английский - NLM (National Library of Medicine)

olanzapine tablet

indoco remedies limited - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - oral olanzapine tablets are indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13-17), efficacy was established in one 6-week trial [see clinical studies (14.1)]. when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions (5.5)]. monotherapy — oral olanzapine tablets are indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disorder. efficacy was established in three clinical trials in adult patients

BALANCE 4.25 % GLUCOSE 1.25 MMOLL CALCIUM Израиль - английский - Ministry of Health

balance 4.25 % glucose 1.25 mmoll calcium

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; glucose monohydrate; magnesium chloride hexahydrate; sodium (s) - lactate; sodium chloride - solution for peritoneal dialysis - sodium (s) - lactate 3.925 g / 1 l; glucose monohydrate 46.75 g / 1 l; magnesium chloride hexahydrate 0.1017 g / 1 l; calcium chloride dihydrate 0.1838 g / 1 l; sodium chloride 5.640 g / 1 l - sodium chloride - end-stage (decompensated) chronic renal failure of any origin which can be treated with peritoneal dialysis.

BALANCE 4.25 % GLUCOSE 1.75 MMOLL CALCIUM Израиль - английский - Ministry of Health

balance 4.25 % glucose 1.75 mmoll calcium

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; glucose monohydrate; magnesium chloride hexahydrate; sodium (s) - lactate; sodium chloride - solution for peritoneal dialysis - sodium (s) - lactate 3.925 g / 1 l; glucose monohydrate 46.75 g / 1 l; magnesium chloride hexahydrate 0.1017 g / 1 l; calcium chloride dihydrate 0.2573 g / 1 l; sodium chloride 5.640 g / 1 l - sodium chloride - end-stage (decompensated) chronic renal failure of any origin which can be treated with peritoneal dialysis.

MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION- medroxyprogesterone acetate injection, suspension Соединенные Штаты - английский - NLM (National Library of Medicine)

medroxyprogesterone acetate injectable suspension- medroxyprogesterone acetate injection, suspension

hikma pharmaceuticals usa inc. - medroxyprogesterone acetate (unii: c2qi4ioi2g) (medroxyprogesterone - unii:hsu1c9yres) - medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy. limitations of use : the use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see dosage and administration (2.1) and warnings and precautions (5.1)]. the use of medroxyprogesterone acetate injectable suspension is contraindicated in the following conditions: medroxyprogesterone acetate injectable suspension should not be administered during pregnancy. [see contraindications and warnings and precautions (5.17).] medroxyprogesterone acetate injectable suspension is not indicated before menarche. use of medroxyprogesterone acetate injectable suspension is associated with significant loss of bmd. this loss of bmd is of particular concern during adolescence and early adulthood, a critical period of bone accretion. in adolescents, interpretation of bm